1
|
Hu Y, Wu J, Li S and Zhao X: Correlation
between CT features and liver function and p53 expression in
hepatitis, cirrhosis and hepatocellular carcinoma. Oncol Lett.
16:4297–4302. 2018.PubMed/NCBI
|
2
|
Imamura H, Matsuyama Y, Tanaka E, Ohkubo
T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T,
Kawasaki S and Makuuchi M: Risk factors contributing to early and
late phase intrahepatic recurrence of hepatocellular carcinoma
after hepatectomy. J Hepatol. 38:200–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ariizumi S, Kitagawa K, Kotera Y,
Takahashi Y, Katagiri S, Kuwatsuru R and Yamamoto M: A non-smooth
tumor margin in the hepatobiliary phase of gadoxetic acid disodium
(Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts
microscopic portal vein invasion, intrahepatic metastasis, and
early recurrence after hepatectomy in patients with hepatocellular
carcinoma. J Hepatobiliary Pancreat Sci. 18:575–585. 2011.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG
and Qu Q: Edmondson-Steiner grade: A crucial predictor of
recurrence and survival in hepatocellular carcinoma without
microvascular invasio. Pathol Res Pract. 213:824–830. 2017.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Nathan H, Schulick RD, Choti MA and Pawlik
TM: Predictors of survival after resection of early hepatocellular
carcinoma. Ann Surg. 249:799–805. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Kim JH, Min YW, Gwak GY, Paik YH, Choi MS,
Lee JH, Koh KC and Paik SW: The utility of gadoxetic acid-enhanced
magnetic resonance imaging in the surveillance for postoperative
recurrence of hepatocellular carcinoma. Medicine (Baltimore).
95:e56662016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Peng Z, Jiang M, Cai H, Chan T, Dong Z,
Luo Y, Li ZP and Feng ST: Gd-EOB-DTPA-enhanced magnetic resonance
imaging combined with T1 mapping predicts the degree of
differentiation in hepatocellular carcinoma. BMC Cancer.
16:6252016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Chang WC, Chen RC, Chou CT, Lin CY, Yu CY,
Liu CH, Chou JM, Hsu HH and Huang GS: Histological grade of
hepatocellular carcinoma correlates with arterial enhancement on
gadoxetic acid-enhanced and diffusion-weighted MR images. Abdom
Imaging. 39:1202–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
9
|
An C, Park MS, Jeon HM, Kim YE, Chung WS,
Chung YE, Kim MJ and Kim KW: Prediction of the histopathological
grade of hepatocellular carcinoma using qualitative
diffusion-weighted, dynamic, and hepatobiliary phase MRI. Eur
Radiol. 22:1701–1708. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Nassif A, Jia J, Keiser M, Oswald S,
Modess C, Nagel S, Weitschies W, Hosten N, Siegmund W and Kuhn JP:
Visualization of hepatic uptake transporter function in healthy
subjects by using gadoxetic acid-enhanced MR imaging. Radiology.
264:741–750. 2012. View Article : Google Scholar : PubMed/NCBI
|
11
|
Kogita S, Imai Y, Okada M, Kim T, Onishi
H, Takamura M, Fukuda K, Igura T, Sawai Y, Morimoto O, et al:
Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular
carcinoma: Correlation with histological grading and portal blood
flow. Eur Radiol. 20:2405–2413. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Lee SA, Lee CH, Jung WY, Lee J, Choi JW,
Kim KA and Park CM: Paradoxical high signal intensity of
hepatocellular carcinoma in the hepatobiliary phase of Gd-EOB-DTPA
enhanced MRI: Initial experience. Magn Reson Imaging. 29:83–90.
2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zeng MS, Ye HY, Guo L, Peng WJ, Lu JP,
Teng GJ, Huan Y, Li P, Xu JR, Liang CH and Breuer J:
Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver
lesions in Chinese patients: A multicenter, open-label, phase III
study. Hepatobiliary Pancreat Dis Int. 12:607–616. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Park JH, Kang JH, Lee YJ, Kim KI, Lee TS,
Kim KM, Park JA, Ko YO, Yu DY, Nahm SS, et al: Evaluation of
diethylnitrosamine- or hepatitis B virus X gene-induced
hepatocellular carcinoma with 18F-FDG PET/CT: A preclinical study.
Oncol Rep. 33:347–353. 2015. View Article : Google Scholar : PubMed/NCBI
|
15
|
Haimerl M, Verloh N, Zeman F, Fellner C,
Muller-Wille R, Schreyer AG, Stroszczynski C and Wiggermann P:
Assessment of clinical signs of liver cirrhosis using T1 mapping on
Gd-EOB-DTPA-enhanced 3T MRI. PLoS One. 8:e856582013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang
LJ, Yang TF and Huang ZK: Comparison of 10- and 20-min
hepatobiliary phase images on Gd-EOB-DTPA-enhanced MRI T1 mapping
for liver function assessment in clinic. Abdom Radiol (NY).
42:2272–2278. 2017. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ding Y, Rao SX, Zhu T, Chen CZ, Li RC and
Zeng MS: Liver fibrosis staging using T1 mapping on gadoxetic
acid-enhanced MRI compared with DW imaging. Clin Radiol.
70:1096–1103. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Yoshimura N, Saito K, Saguchi T, Funatsu
T, Araki Y, Akata S and Tokuuye K: Distinguishing hepatic
hemangiomas from metastatic tumors using T1 mapping on
gadoxetic-acid-enhanced MRI. Magn Reson Imaging. 31:23–27. 2013.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhou ZP, Long LL, Qiu WJ, Cheng G, Huang
LJ, Yang TF and Huang ZK: Evaluating segmental liver function using
T1 mapping on Gd-EOB-DTPA-enhanced MRI with a 3.0 Tesla. BMC Med
Imaging. 17:202017. View Article : Google Scholar : PubMed/NCBI
|
20
|
Peng Z, Li C, Chan T, Cai H, Luo Y, Dong
Z, Li ZP and Feng ST: Quantitative evaluation of Gd-EOB-DTPA uptake
in focal liver lesions by using T1 mapping: Differences between
hepatocellular carcinoma, hepatic focal nodular hyperplasia and
cavernous hemangioma. Oncotarget. 8:65435–65444. 2017.PubMed/NCBI
|
21
|
Wang WT, Zhu S, Ding Y, Yang L, Chen CZ,
Ye QH, Ji Y, Zeng MS and Rao SX: T1 mapping on gadoxetic
acid-enhanced MR imaging predicts recurrence of hepatocellular
carcinoma after hepatectomy. Eur J Radiol. 103:25–31. 2018.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Llovet JM, Fuster J and Bruix J: Prognosis
of hepatocellular carcinoma. Hepatogastroenterology. 49:7–11.
2002.PubMed/NCBI
|
23
|
Edmondson HA and Steiner PE: Primary
carcinoma of the liver: A study of 100 cases among 48,900
necropsies. Cancer. 7:462–503. 1954. View Article : Google Scholar : PubMed/NCBI
|
24
|
Bae KE, Kim SY, Lee SS, Kim KW, Won HJ,
Shin YM, Kim PN and Lee MG: Assessment of hepatic function with
Gd-EOB-DTPA-enhanced hepatic MRI. Dig Dis. 30:617–622. 2012.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Zhang W, Tan Y, Jiang L, Yan L, Li B, Wen
T and Yang J: Liver resection associated with better outcomes for
single large hepatocellular carcinoma located in the same section.
Medicine (Baltimore). 96:e62462017. View Article : Google Scholar : PubMed/NCBI
|
26
|
Liu K, Hao M, Ouyang Y, Zheng J and Chen
D: CD133(+) cancer stem cells promoted by VEGF accelerate the
recurrence of hepatocellular carcinoma. Sci Rep. 7:414992017.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Barreto SG, Brooke-Smith M, Dolan P,
Wilson TG, Padbury RT and Chen JW: Cirrhosis and microvascular
invasion predict outcomes in hepatocellular carcinoma. ANZ J Surg.
83:331–335. 2013. View Article : Google Scholar : PubMed/NCBI
|
28
|
Park YK, Kim BW, Wang HJ and Kim MW:
Hepatic resection for hepatocellular carcinoma meeting Milan
criteria in Child-Turcotte-Pugh class a patients with cirrhosis.
Transplant Proc. 41:1691–1697. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Tsuda N and Matsui O: Cirrhotic rat liver:
Reference to transporter activity and morphologic changes in bile
canaliculi-gadoxetic acid-enhanced MR imaging. Radiology.
256:767–773. 2010. View Article : Google Scholar : PubMed/NCBI
|
30
|
Norén B, Dahlström N, Forsgren MF,
Dahlqvist Leinhard O, Kechagias S, Almer S, Wirell S, Smedby Ö and
Lundberg P: Visual assessment of biliary excretion of Gd-EOB-DTPA
in patients with suspected diffuse liver disease-A biopsy-verified
prospective study. Eur J Radiol Open. 2:19–25. 2015. View Article : Google Scholar : PubMed/NCBI
|
31
|
Mori Y, Tamai H, Shingaki N, Hayami S,
Ueno M, Maeda Y, Moribata K, Deguchi H, Niwa T, Inoue I, et al:
Hypointense hepatocellular carcinomas on apparent diffusion
coefficient mapping: Pathological features and metastatic
recurrence after hepatectomy. Hepatol Res. 46:634–641. 2016.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Shen J, Liu J, Li C, Wen T, Yan L and Yang
J: The impact of tumor differentiation on the prognosis of
HBV-associated solitary hepatocellular carcinoma following
hepatectomy: A propensity score matching analysis. Dig Dis Sci.
63:1962–1969. 2018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Kok B and Abraldes JG: Child-pugh
classification: Time to abandon? Semin Liver Dis. 39:96–103. 2019.
View Article : Google Scholar : PubMed/NCBI
|